A clinical study to evaluate the effects of RO7795068 in participants with obesity or overweight without type 2 diabetes.
Study Sponsor: F. Hoffmann-La Roche Ltd
Location: International Diabetes Center
Phase of Study: Phase III
Purpose of study: This study is being done to evaluate a new investigational medication for weight management in adults with overweight or obesity. The medication may reduce appetite. The study will see how well the medication works compared to a placebo. A placebo looks like the study drug but has no active ingredient.
What is the cost?
You can participate in this study at no cost. Your participation is completely voluntary.
What happens in the study?
You will be asked to:
– Attend regular study visits for about 18 months
– Have your blood drawn and complete other study procedures
– Take study medicine weekly
– Complete questionnaires using an e-diary
Participants will receive:
– Compensation for completed study visits
– Guidance by nutrition professionals
– Study-related medical care, including regular lab tests, at no cost
Inclusion Criteria:
You may be eligible if you:
– Are 18 years of age or older
– Do not have diabetes
– Have a BMI greater than 27
– Are interested in weight loss
– Are not currently taking weight-loss medication
– Meet other study specific requirements
Study Contact:
Caitlin Moening
(952) 993-9605
IDCResearch@parknicollet.com
Limpet Study: Advancing Ostomy and Enteric Fistula Care
Study Sponsor: Fistula Solution
Location: HealthPartners Specialty Center
Phase of Study: Pivotal Trial
Purpose of study: The purpose of the study is to determine if a new ostomy pouch wound management device, called the Limpet, prevents complications and improves the quality of life for people living with an ostomy and/or fistula compared to the current pouch devices used.
Inclusion Criteria:
– 18 years of age or older
– Undergone ileostomy surgery, have a pre-existing ileostomy with skin damage or have a fistula
Additional inclusion/exclusion criteria apply. Please contact the study team for more information.
Exclusion Criteria:
– Scheduling/planning chemotherapy or other radiation treatment
– Pregnant
– Unable/unwilling to attend follow-up appointments
Additional inclusion/exclusion criteria apply. Please contact the study team for more information.
Study Contact:
Allison Kehren
(651) 254-5342
allison.j.kehren@healthpartners.com
